Sei Investments »

Lineage Cell Therapeutics In shares owned by Sei Investments

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Sei Investments from 13F filings

Historical chart of Sei Investments investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Sei Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Sei Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $450k 269k 1.67

More positions owned by Sei Investments

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Ishares Tr Core Msci Intl (IDEV)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Value Etf (VTV)

View all positions for Sei Investments

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Defender Capital
Raffles Associates
Brian McDonald
BlackRock
Millennium Management
Geode Capital Management
Renaissance Technologies
Goldman Sachs Group
Marshall Wace
State Street Corporation
Jane Street
Susquehanna International
Red Crane Wealth Management

View all funds holding Lineage Cell Therapeutics In